Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

How to be a patient in the Haukeland rituximab study

Discussion in 'Active Clinical Studies' started by Sasha, Sep 5, 2013.

  1. Sasha

    Sasha Fine, thank you

    Messages:
    14,461
    Likes:
    30,335
    UK
  2. Legendrew

    Legendrew Content team

    Messages:
    540
    Likes:
    729
    UK
    Good to see they're taking patient selection very seriously as in their previous trials.
     
    SOC and Sasha like this.

See more popular forum discussions.

Share This Page